Moreover, extramedullary involvement both at diagnosis and in relapse is relatively frequent in CBFA2T3::GLIS2-positive leukemia patients compared with AML patients without this genetic aberration [15,45,46]. The gene discussed is GLIS2; the disease is leukemia.